Propel Bio Management, LLC TCRX Holdings History
Number of Shares
2.09 Mil
Current Holdings Value*
$2.88 Mil
% of Portfolio
3.39%
Total Estimate Gain
$-5.61 Mil
% of Total Estimate Gain
-58.73%
Propel Bio Management, LLC's TScan Therapeutics Inc Holding Summary
As of 2025-03-31, Propel Bio Management, LLC held 2.09 Mil shares of TScan Therapeutics Inc(TCRX), totaling $2.88 Mil. This investment constitutes 3.39% of their stock portfolio, and Propel Bio Management, LLC now holds 3.69% of the outstanding TScan Therapeutics Inc(TCRX) stock.
The initial trade took place in 2023Q4. Based on historical transaction data and TCRX's current price of $1.89, Propel Bio Management, LLC's estimated gain on his TCRX holdings is $-5.61 Mil, reflecting a -58.73% gain to date.
Propel Bio Management, LLC TCRX ($1.89) Holding Chart
Propel Bio Management, LLC TCRX ($1.89) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers